Legal & General Group’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $586K | Buy |
63,029
+526
| +0.8% | +$4.89K | ﹤0.01% | 2399 |
|
|
2025
Q1 | $421K | Buy |
62,503
+20,510
| +49% | +$138K | ﹤0.01% | 2448 |
|
|
2024
Q4 | $446K | Sell |
41,993
-90
| -0.2% | -$956 | ﹤0.01% | 2496 |
|
|
2024
Q3 | $615K | Buy |
42,083
+222
| +0.5% | +$3.25K | ﹤0.01% | 2393 |
|
|
2024
Q2 | $507K | Buy |
41,861
+11,133
| +36% | +$135K | ﹤0.01% | 2417 |
|
|
2024
Q1 | $758K | Buy |
+30,728
| New | +$758K | ﹤0.01% | 2282 |
|
|
2021
Q2 | – | Sell |
-207
| Closed | -$7K | – | 3574 |
|
|
2021
Q1 | $7K | Buy |
+207
| New | +$7K | ﹤0.01% | 3448 |
|